Cargando…

Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions

BACKGROUND: Progressive multifocal leukoencephalopathy (PML) can rarely occur in Multiple Sclerosis (MS) patients undergoing dimethyl fumarate (DMF) treatment. Our case stresses the limits of current diagnostic and stratification risk criteria, highlighting the potential role of Magnetic Resonance I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vola, Elena Augusta, Petracca, Maria, Cocozza, Sirio, De Angelis, Marcello, Carotenuto, Antonio, Pontillo, Giuseppe, Morra, Vincenzo Brescia, Tedeschi, Enrico, Lanzillo, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020541/ https://www.ncbi.nlm.nih.gov/pubmed/33820529 http://dx.doi.org/10.1186/s12883-021-02165-0

Ejemplares similares

Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study
por: Pontillo, Giuseppe, et al.
Publicado: (2017)

Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis
por: Petracca, Maria, et al.
Publicado: (2021)

Cognitive trajectories in multiple sclerosis: a long-term follow-up study
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Correction to: Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin
por: Pontillo, Giuseppe, et al.
Publicado: (2022)

Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin
por: Pontillo, Giuseppe, et al.
Publicado: (2022)

Progressive multifocal leukoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate
por: Lyons, Jennifer, et al.
Publicado: (2022)

Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate
por: Dammeier, Nele, et al.
Publicado: (2015)

CORRIGENDUM to Progressive multifocal leukoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate
Publicado: (2023)

Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis
por: Ugga, Lorenzo, et al.
Publicado: (2018)

Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice
por: De Angelis, Marcello, et al.
Publicado: (2020)

Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis
por: Hoepner, Robert, et al.
Publicado: (2015)

Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach
por: Pontillo, Giuseppe, et al.
Publicado: (2022)

Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis
por: Caliendo, Daniele, et al.
Publicado: (2023)

Longitudinal Assessment of Dentate Nuclei Relaxometry during Massive Gadobutrol Exposure
por: Tedeschi, Enrico, et al.
Publicado: (2017)

Reduced Intracranial Volume in Fabry Disease: Evidence of Abnormal Neurodevelopment?
por: Pontillo, Giuseppe, et al.
Publicado: (2018)

Retinal and Choriocapillary Vascular Changes in Early Stages of Multiple Sclerosis: A Prospective Study
por: Montorio, Daniela, et al.
Publicado: (2021)

Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review
por: De Angelis, Marcello, et al.
Publicado: (2021)

AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature
por: Spiezia, Antonio Luca, et al.
Publicado: (2022)

Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials
por: Moccia, Marcello, et al.
Publicado: (2020)

Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
por: Zanghì, Aurora, et al.
Publicado: (2021)

A Retrospective Exploratory Analysis on Cardiovascular Risk and Cognitive Dysfunction in Multiple Sclerosis
por: Reia, Antonio, et al.
Publicado: (2021)

Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy
por: Moccia, Marcello, et al.
Publicado: (2022)

Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience
por: Rosa, Laura, et al.
Publicado: (2022)

Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015)

Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015
por: Moccia, Marcello, et al.
Publicado: (2017)

Motor involvement in Fabry disease
por: Cocozza, Sirio, et al.
Publicado: (2017)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis
por: Cennamo, Gilda, et al.
Publicado: (2020)

Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)
por: Moccia, Marcello, et al.
Publicado: (2020)

Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia
por: Jasoliya, Mittal, et al.
Publicado: (2019)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study
por: Capasso, Nicola, et al.
Publicado: (2022)

Social Media and Multiple Sclerosis in the Posttruth Age
por: Lavorgna, Luigi, et al.
Publicado: (2017)

Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2019)

Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data
por: Moccia, Marcello, et al.
Publicado: (2021)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
por: Novarella, Federica, et al.
Publicado: (2022)

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient?
por: Johansen, Krisztina K., et al.
Publicado: (2013)

Progressive multifocal leukoencephalopathy in an immunocompetent patient
por: van der Kolk, Nicolien M., et al.
Publicado: (2016)

Diagnostic delay in progressive multifocal leukoencephalopathy
por: Miskin, Dhanashri P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bmlmojrskjoljcv8l00aocmthp